Moreover, miR-150-5p in CRC can inhibit HUVEC tube-forming ability and inhibit CRC tumor progression by targeting VEGFA in CRC through VEGFA/VEGFR2/Akt/mTOR signaling pathway (75). Here, MTOR is linked to colorectal carcinoma.